Letrozole Tablet
Product Images NDC 71335-1526

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Letrozole (NDC 71335-1526). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl713351526)

This is a medication package of Letrozole 2.5mg tablets, packaged by Bryant Ranch Prepack in Burbank with a National Drug Code of 7133515261. The tablets are round and yellow in color and are to be stored at room temperature between 20-25°C (68°-77°F). It is comparable to the medication Femara 2.5mg Tablet and comes in a package of 30 tablets with an expiration date of MM/YY. It is recommended to keep all drugs out of the reach of children.*

FDA Label Image

Chemical Structure (Letrozole 01)

FDA Label Image

Figure 1 (Letrozole 02)

FDA Label Image

Figure 2 (Letrozole 03)

This is a simple phrase indicating the number of months during which a patient's condition remained stable and did not progress. There is not enough context to determine any specific medical condition or treatment.*

FDA Label Image

Figure 3 (Letrozole 04)

FDA Label Image

Figure 4 (Letrozole 05)

FDA Label Image

Figure 5 (Letrozole 06)

The text is a graph or chart showing the Time to Progression (in days) for a treatment group that received Letrozole Tablets 0.5mg. The graph has ten points corresponding to the number of days and the treatment outcome. The text also mentions Letrozole Tablets 25mg and AG, but it is unclear how these relate to the graph.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.